 - are documented to be sterile or consistently and correctly use a condom while their female partners if of childbearing potential agree to use any of the following adequate contraception methods: implants, injectables, combined oral contraceptives, intrauterine device IUD from the date of screening until at least 6 months after the last dose of BI 655064 taken in the current trial. 